Dublin, Ireland, 18 November 2022 – CroíValve has announced the successful First in Human implants of its DUO Tricuspid Coaptation Valve technology for the treatment of Tricuspid Regurgitation as part of its TANDEM I study in Poland. The procedures were performed as part of an ongoing clinical trial at the National Institute of Cardiology, Warsaw by Prof Adam Witkowski and Dr Maciej Dąbrowski and the Medical University of Silesia in Katowice by Prof Wojciech Wojakowski.